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ABSTRACT 
 
Worldwide mortality and morbidity from infectious diseases is being 
replaced by chronic diseases, such as cancer, obesity and type II diabetes, 
cardiovascular diseases, neurodegenerative diseases and aging which involve 
inflammation. Vascular endothelial growth factor (VEGF) as a potent pro-
inflammatory cytokine is elevated in many human diseases, or animal models 
of human disease, which are mentioned above. Compounds derived from 
botanic sources, such as polyphenolic compounds, have shown anti-
inflammatory activity. These natural compounds express anti-inflammatory 
activity by modulation of pro-inflammatory gene expression. 
We hypothesized this effect may related to control regulation of VEGF gene 
promoter. In this study, 5` flanking region of the VEGF promoter were 
isolated using nested PCR to define the transcription factors binding sites. The 
human VEGF promoter region was cloned in DH5 alpha for future 
investigation. 
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ABSTRAK 
 
Kadar kematian dan morbiditas di dunia disebabkan oleh penyakit 
sedang digantikan oleh penyakit kronik, seperti kanser, obesity dan diabetes 
jenis II, penyakit kardiovaskular, penyakit neurodegenerative dan penuaan 
yang melibatkan keradangan. Vascularfaktor pertumbuhan endotel (VEGF) 
sebagai sitokin pro-inflamasi diaplikasikan kepada berbagi jenis penyakit 
manusia, atau model binatang dari penyakit manusia, seperti yang disebut di 
atas. Sebatian yang berasal dari sumber botani, seperti sebatian polifenol,telah 
menunjukkan aktiviti anti-inflamasi. Sebatian semulajadi mengekspresikan 
aktiviti anti-inflamasi dengan modulasi ekspresi gen pro-inflamasi. Secara 
hipotesis kesan ini mungkin berkaitan dengan kawalan peraturan promoter 
gen VEGF. Dalam kajian ini, 5 ` flanking region dari promoter VEGF adalah 
dipencilkan menggunakan nested PCR untuk menentukan faktor-faktor 
transkripsi binding site. Wilayah VEGF promoter manusia pengklonan ke 
dalam alpha DH5 untuk penyelidikan pada masa depan. 
 
. 
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CHAPTER 1 
 
 
 
INTRODUCTION 
 
 
 
1.1 Introduction 
 
Inflammation is a biological response of vascular tissues to harmful 
stimuli, such as pathogens, damaged cells, or irritants. It is a protective effort 
by the organism in response to injurious stimuli as well as initiates the healing 
process for the tissue. 
 
In the absence of inflammation, wounds and infections would never 
heal. However, chronic inflammation can also lead to a host of diseases, such 
as high fever, atherosclerosis and rheumatoid arthritis. One of the cells 
responsible in inflammation is endothelial cells. VEGF (Vascular endothelial 
growth factor) is an endothelial cell-specific mitogen that is structurally 
related to platelet-derived growth factor (Tischer et al., 1991). 
 
2 
 
On the other hand Angiogenesis is the key process involved in normal 
development and wound repair and is motivated by different kinds of growth 
factors for instance vascular endothelial growth factor (VEGF) (Ushio-Fukai, 
2006) which is crucial angiogenic growth factor. VEGF stimulates 
proliferation, migration, and tube formation; three different stages of 
Angiogenesis in endothelial cells (ECs) (Ushio-Fukai, 2006).  
 
Analysis of VEGF transcripts in vascular smooth muscle cells by 
Polymerase Chain Reaction(PCR) and cDNA cloning revealed three different 
forms of the VEGF in human-coding region including 189, 165, and 121 
amino acids in length (Tischer et al., 1991). 
 
In brief VEGF main function is to produce new blood vessels 
throughout embryonic development. In adult human they are responsible in 
recovering vascular injuries, by creating new vessels to evade blocked vessels. 
 
 
 
1.2 Problem statement 
 
Excessive inflammation is considered critical factor in many human 
diseases, including cancer, obesity, type II diabetes, cardiovascular diseases, 
neurodegenerative diseases and aging. 
 
 VEGF has been shown to increase vascular leak of both proteins and 
particulates or permeability, which is necessary prerequisite for the induction 
of angiogenesis. It is proposed that VEGF levels increase before and/or during 
the angiogenic process. This changes in VEGF level is observed in many 
human diseases which are characterized by inflammation and vascular leak, 
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for instance cerebral ischemia, tumor ascites, trauma, early diabetic 
retinopathy, preeclampsia, ovarian hyper stimulation syndrome, and status 
epilepticus. 
VEGF acts either directly or indirectly as a potent pro-inflammatory 
cytokine; and as it mentioned above that increases in vascular permeability 
and it is an index of inflammation precede VEGF-induced angiogenesis (Croll 
et al., 2004). 
 
Some compounds extracted from botanic sources, such as phenolic 
compounds, have shown anti-inflammatory activity in vitro and in vivo. They 
express some anti-inflammatory activity such as cyclooxygenase, 
lipoxygenase, nitric oxide synthases and several cytokines, mainly by acting 
through nuclear factor-kappa B and mitogen-activated protein kinase signaling 
(Santangelo et al., 2007). 
 
Polyphenols comprise one of the most numerous dispersed group of 
plant secondary metabolites, present in all plants that are commonly 
consumed in the Mediterranean diet containing fruits, vegetables, grains, 
legumes, tea, red wine and extra virgin olive oil (eVOO) (Santangelo et al., 
2007). Although the function of VEGF is well studied the mechanism involve 
in its expression is vague. Hence the aim of this study is to isolate the 
promoter region that controls the expression of this important gene in order to 
investigate the factor that may influence its expression. 
 
 
 
 
 
 
4 
 
1.3  The specific objectives of this study are; 
 
1) To  characterize the regulatory regions of promoter by using bioinformatic 
tools 
2)  To isolate the promoter region of VEGF gene  
3)  To clone the  promoter in PGL3 Basic vector  
4) To transform VEGF promoter  construct to DH5α competent cells  
 
 
 
1.4  Scope of study 
  The scope of this study is to isolate and identify the human VEGF 
promoter which involves the genomic extraction from fresh blood and 
bioinformatic tools respectively. Designing suitable primer and cloned the 
VEGF promoter in PGL3 reporter vector. 
 
 
 
1.5  Significance of study 
 
Regarding that inflammation represents a major pathologic basis for 
the majority of human malignancies and some other kinds of disease such as 
type II diabetes, cardiovascular diseases and neurodegenerative diseases. 
Understanding of the mechanism involve is important in order to find a way to 
control this problem. 
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